-
SpeichernDas Eingabefeld wird
gespeichert wenn Sie das Feld
verlassen oder hier klicken.↓
Börse NasdaqISIN US03475V1017
ISIN US03475V1017
WKN A0B9A5
Symbol ANGO
Börse
Nasdaq Zeitzone: Europe/Berlin
Firmenname
AngioDynamics, Inc
Marktkapitalisierung
751.485.280 (+- 2%)
Die einen sagen so, die anderen so... Es gibt 2 Datenquellen:
764.970.560 oder 738.000.000
Mitarbeiter
780 (+- 3%)
Die einen sagen so, die anderen so... Es gibt 2 Datenquellen:
800 oder 760 Mitarbeiter
KGV
7.1
EBITDA 5.320.000
PEGRatio 1.87
Buchwert 11.853
AngioDynamics underperformed den DAX um -14 % vom 04.10.2013 bis 07.05.2014
Die letzten Quartalsergebnisse Erwarteter Gewinn je Aktie beim aktuellen Wert von 23,6 USD -0,42%
Portrait der AngioDynamics Aktie
Das Unternehmen AngioDynamics, Inc aus USA beschäftigt 780 Mitarbeiter und ist in den Bereichen Chemie & Pharma, Medizinische Produkte / Medizintechnik, Medizinische Geräte tätig.
Die AngioDynamics Aktie konnte seit dem 04.10.2013 leider keine Rendite erwirtschaften. Die Kursverluste lagen bei -3%.
Das Unternehmen AngioDynamics, Inc ist nur in 7 ETFs enthalten und somit eine nicht sonderlich bekannte oder beliebte Aktie. Der Spitzenreiter Global X Longevity Thematic ETF gewichtet AngioDynamics mit 0,31% im ETF.
Entdecke die 6 ETFs in denen AngioDynamics, Inc am höchsten gewichtet ist Insgesamt in 7 ETFs enthalten
Dir gefallen die Informationen zu AngioDynamics?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn Ihr meine Arbeit unterstützen möchtet, dann eröffnet gerne ein kostenloses und unverbindliches Depot bei Trade Republic mit der Möglichkeit kostenlos Aktien zu besparen. Wenn du das über meinen Link machst, bekommst du und ich bei deinem ersten Wertpapierkauf 15 von Trade Republic geschenkt:
Zu Trade Republic
Dir gefallen die Informationen zu AngioDynamics?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn du meine Arbeit unterstützen möchtest, dann eröffne ein kostenloses und unverbindliches Depot bei BUX Zero mit der Möglichkeit kostenlos US-Aktien und für einen Euro viele weitere Aktien aus Deutschland, Belgien, Niederlande, sterreich oder UK zu kaufen. Wenn du das über meinen Link machst, bekommen wir beide eine gratis Aktie geschenkt:
Zu BUX Zero
Dir gefallen die Informationen zu AngioDynamics?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn du meine Arbeit unterstützen möchtest, dann eröffne gerne ein kostenloses und unverbindliches Depot bei der ING Diba. Ich erhalte 20 wenn du daraufhin dann zum Beispiel einen Aktien-Sparplan anlegst oder etwas kaufst:
Zur ING Diba
Dir gefallen die Informationen zu AngioDynamics?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn Ihr meine Arbeit unterstützen möchtet, dann eröffnet gerne ein mindestens 3 Jahre lang kostenloses Depot bei der comdirect. Wenn du das über diesen Link machst unterstützt du auch meine Tochter Zoe, da es Ihr Juniordepot ist. Sie erhält 20 und bei einem aktiven ETF- oder Aktien-Sparplan bleibt dein Depot auch danach kostenfrei:
Zur Comdirect
32 News & Informationen zur AngioDynamics Aktie
Lapides Asset Management, LLC Buys Cinemark Holdings Inc, Plantronics Inc, Universal Electronics Inc, Sells NCR Corp, Teradata Corp, AngioDynamics Inc
GuruFocus Article or News written by insider and the topic is about:
After Beating Estimates, Is This Little-Known Medical Device Company a Buy?
AngioDynamics exceeded analyst expectations on revenue in Q4 2021, but does that make it worth buying?
Global Interventional Oncology Devices Market 2021-2030: Focus On Thermal Tumor Ablation, Non-thermal Tumor Ablation, TACE, SIRT, TAE, Bland Embolization
DUBLIN, July 16, 2021 /PRNewswire/ — The “Interventional Oncology Devices Global Market Report 2021: COVID-19 Growth and Change to 2030” report has been added
Cardiac Ablation Market Records a CAGR of 7.51% by 2025|COVID-19 Impact Analysis|Technavio
/PRNewswire/ — The cardiac ablation market is expected to grow by USD 1.67 billion during 2021-2025, according to Technavio. The report offers a detailed…
Global Central Venous Catheters (CVCs) Market To Reach $1.5 Billion By 2026
SAN FRANCISCO, July 14, 2021 /PRNewswire/ — A new market study published by Global Industry Analysts Inc., (GIA) the premier market research company, today
Global Central Venous Catheters (CVCs) Market to Reach $1.5 Billion by 2026
SAN FRANCISCO, July 14, 2021 /PRNewswire/ — A new market study published by Global Industry Analysts Inc., (GIA) the premier market research comp…
AngioDynamics (ANGO) Q4 Earnings Match Estimates, Revenues Top
AngioDynamics (ANGO) registers strong revenue growth across all its GBUs in fiscal 2021 Q4.
AngioDynamics, Inc. (ANGO) CEO Jim Clemmer on Q4 2021 Results – Earnings Call Transcript
AngioDynamics, Inc. (NASDAQ:ANGO) Q4 2021 Earnings Conference Call July 13, 2021 08:00 AM ET Company Participants Jim Clemmer – President and Chief Executive Officer Steve Trowbridge -…
AngioDynamics, Inc. 2021 Q4 – Results – Earnings Call Presentation (NASDAQ:ANGO)
The following slide deck was published by AngioDynamics, Inc.
AngioDynamics Q4 Loss Narrows In Line With Estimates
(RTTNews) – AngioDynamics, Inc. (ANGO) on Tuesday reported net loss of $19.5 million, or $0.51 per share, in the fourth quarter, narrower than $15…
Global lung cancer surgery market size to touch USD 7 billion by 2027
The latest research literature report on ‘global lung cancer market’ deeply explores all critical factors like shares, size, growth drivers, obstacles, and…
Earnings Scheduled For July 13, 2021
Companies Reporting Before The Bell
• OrganiGram Holdings (NASDAQ:OGI) is estimated to report quarterly loss at $0.03 per share on revenue of …
The Week Ahead In Biotech: Adcom Test Awaits FibroGen, Data Readouts, IPOs In The Mix
Biopharma stocks closed the holiday-shortened week lower amid a lack of any significant news flow. On the drug approval front, Provention Bio, In…
Stocks That Hit 52-Week Highs On Friday
Before 10 a.m. ET on Friday, 115 companies hit new 52-week highs.
Interesting Points: The largest company on a market cap basis to set a new …
AngioDynamics Announces Details For Investor & Technology Day On July 13, 2021
AngioDynamics, Inc. ANGO, a leading provider of innovative, minimally invasive medical devices for vascular access, peripheral vascular disease, and oncology,
Insights on the Tumor Ablation Global Market to 2026 – by Technology, Mode of Treatment, Mode of Application, End-user and Region
/PRNewswire/ — The “Tumor Ablation Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026” report has been added to…
Insights On The Tumor Ablation Global Market To 2026 – By Technology, Mode Of Treatment, Mode Of Application, End-user And Region
DUBLIN, July 5, 2021 /PRNewswire/ — The “Tumor Ablation Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026” report has
Global Dialysis Market Size on Track to Top $129.75 Billion by 2028: Allied Market Research
Portland, OR, June 29, 2021 (GLOBE NEWSWIRE) — As per the report published by Allied Market Research, the global Dialysis Market was pegged at $91.20 …
Global Dialysis Market Size on Track to Top $129.75 Billion by 2028: Allied Market Research
Rise in incidences of kidney diseases, surge in prevalence of lifestyle and chronic diseases, and issues related to kidney transplants drive the growth of…
Stocks That Hit 52-Week Highs On Friday
This morning 143 companies set new 52-week highs.
Noteables: Adobe (NASDAQ:ADBE) was the biggest company by market cap to set a new 52-week …
AngioDynamics To Report Fiscal 2021 Fourth Quarter And Full-Year Financial Results And Host Investor & Technology Day On July 13, 2021
AngioDynamics, Inc. ANGO, a leading provider of innovative, minimally invasive medical devices for vascular access, peripheral vascular disease, and oncology,
Stocks That Hit 52-Week Highs On Wednesday
This morning 122 companies reached new 52-week highs.
Interesting Facts: The largest company on a market cap basis to set a new 52-week high …
AngioDynamics (ANGO) Presents At 20th Annual Needham Virtual Healthcare Conference – Slideshow (NASDAQ:ANGO)
The following slide deck was published by AngioDynamics, Inc.
EDGAR Filing Documents for 0000914121-21-002530
What Makes AngioDynamics (ANGO) a Strong Momentum Stock: Buy Now?
Does AngioDynamics (ANGO) have what it takes to be a top stock pick for momentum investors? Let's find out.
AngioDynamics (ANGO) Upgraded to Strong Buy: Here's What You Should Know
AngioDynamics (ANGO) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).
EDGAR Filing Documents for 0000914121-21-000070
EDGAR Filing Documents for 0001275187-21-000005
Stocks That Hit 52-Week Highs On Friday
This morning 470 companies set new 52-week highs.
Facts of Interest: Tesla (NASDAQ:TSLA) was the largest firm on a market cap basis to set a …
The Daily Biotech Pulse: Sarepta Gene Therapy Study Readout, Novavax Vaccine Supply Deal, 2 IPOs
Here's a roundup of top developments in the biotech space over the last 24 hours.
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs Jan. 7) …
AngioDynamics (ANGO) Q2 Earnings and Revenues Top Estimates
AngioDynamics (ANGO) witnesses revenue growth across two business segments in fiscal Q2.
AngioDynamics Earnings Preview
AngioDynamics (NASDAQ:ANGO) announces its next round of earnings this Thursday, January 07. Here is Benzinga’s everything-that-matters guide for this …